The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott episode artwork

EPISODE · Mar 10, 2022 · 5 MIN

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott

from Medical Digest & Congress Report · host Medical Congress News

Prof. David F. McDermott shared his thoughts in the kidney cancer filed. What was the biggest changes in the last six months? Video: https://congressreport.eu/scientific-contents/standalonecontent:role-immune-checkpoint-inhibitors-and-vegf-tkis-adjuvant-treatment-renal-cell-carcinoma

Episode metadata supplied by the publisher feed · Published Mar 10, 2022

Embed this episode

Ready to play

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott

0:00 5:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on March 10, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!